Published in Gene Therapy Weekly, July 28th, 1997
Researchers should pursue alternative vector systems and learn a great deal more about cell biology, gene structure and function, and host immune response to gene products and viral proteins, said Harvey G. Klein, M.D., Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health (NIH), Bethesda, Maryland ("Cellular Gene Therapy: a Credible Odyssey," [editorial], Transfusion, July 1997;37:675-677).
He noted that these issues represent a few of the challenges to basic science.
"On a more practical level, we...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.